Generic Hospice

When hospice reverts to the lowest common denominator and leaders obsess about metrics, it's time to speak. Self-inflated leaders assume clinicians give until their backs break, given no raises for years. A clinical ladder is a rainbow’s pot of gold. Others have a sorrier job and must be motivated by money. Abysmal leaders dangle extrinsic rewards for admission, hiring and EDBITA targets. “Sign on” bonuses entice people into a poor work environment. Employees’ voice equals their raise, zero.

Saturday, May 24, 2014

Gentiva Prescribes Poison Pill

StrangeTony,

Reuters reported on Gentiva's poison pill, which the company adopted more than a week after rejecting a $533-million hostile bid from LTAC hospital operator Kindred Healthcare. "Poison pills" are designed to stop hostile takeovers by triggering the issue of new shares that dilute the holdings of investors who exceed a set threshold.

Gentiva set a 15 percent trigger for the rights plan, which will expire on May 20, 2015. Gentiva rejected Kindred's $14-per-share offer on May 15, saying it undervalued the company. Kindred, the water glass is in your lawyers' court.

Anonymous (from Gentiva)

Generic Hospice

Saturday, May 24, 2014

Gentiva Prescribes Poison Pill

No comments:

Post a Comment